News

  1. Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
  2. Checkpoint Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
  3. Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules